Venture capital firm applies pharmaceutical companies' approach to drug discovery to its business model to create an incubation partnership.

Tobira Therapeutics raises $31m in its series B round.

Roche Venture Fund has reinvested in Horizon Discovery's third round of funding.

Eli Lilly and Novartis back Cylene's latest $12m funding in a round reportedly extended more than three years.

Pfizer Ventures' investment extends TetraLogic's series C round, which originally closed last month at $32m.

Swiss Life-backed Phenex Pharmaceuticals closes series C round.

Astellas Venture Management invests $1m in DecImmune Therapeutics.

Argos Therapeutics, a biotechnology company previously known as Merix Bioscience, three-quarters of way through $6m funding round.

Third Rock Ventures and Roche Venture Fund invest $30m in CytomX Therapeutics